PortfoliosLab logoPortfoliosLab logo
SPRO vs. TQQQ
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

SPRO vs. TQQQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Spero Therapeutics, Inc. (SPRO) and ProShares UltraPro QQQ (TQQQ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SPRO achieves a 20.17% return, which is significantly lower than TQQQ's 64.46% return.


SPRO

1D
-1.06%
1M
12.00%
YTD
20.17%
6M
22.81%
1Y
6.06%
3Y*
15.44%
5Y*
-27.74%
10Y*

TQQQ

1D
-0.76%
1M
33.35%
YTD
64.46%
6M
55.93%
1Y
137.89%
3Y*
69.49%
5Y*
28.37%
10Y*
45.33%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SPRO vs. TQQQ - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SPRO
Spero Therapeutics, Inc.
20.17%126.21%-29.93%-15.03%-89.19%-17.43%101.66%56.34%-47.66%2.17%
TQQQ
ProShares UltraPro QQQ
64.46%34.35%58.27%198.04%-79.09%82.98%110.05%133.84%-19.79%7.43%

Correlation

The correlation between SPRO and TQQQ is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.22

Correlation (3Y)
Calculated over the trailing 3-year period

0.21

Correlation (5Y)
Calculated over the trailing 5-year period

0.25

Correlation (All Time)
Calculated using the full available price history since Nov 3, 2017

0.26

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SPRO vs. TQQQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SPRO
SPRO Risk / Return Rank: 4444
Overall Rank
SPRO Sharpe Ratio Rank: 4545
Sharpe Ratio Rank
SPRO Sortino Ratio Rank: 4343
Sortino Ratio Rank
SPRO Omega Ratio Rank: 4242
Omega Ratio Rank
SPRO Calmar Ratio Rank: 4444
Calmar Ratio Rank
SPRO Martin Ratio Rank: 4343
Martin Ratio Rank

TQQQ
TQQQ Risk / Return Rank: 7171
Overall Rank
TQQQ Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
TQQQ Sortino Ratio Rank: 6565
Sortino Ratio Rank
TQQQ Omega Ratio Rank: 6565
Omega Ratio Rank
TQQQ Calmar Ratio Rank: 7373
Calmar Ratio Rank
TQQQ Martin Ratio Rank: 6666
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SPRO vs. TQQQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Spero Therapeutics, Inc. (SPRO) and ProShares UltraPro QQQ (TQQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SPROTQQQDifference

Sharpe ratio

Return per unit of total volatility

0.12

2.92

-2.80

Sortino ratio

Return per unit of downside risk

0.53

3.09

-2.56

Omega ratio

Gain probability vs. loss probability

1.07

1.40

-0.34

Calmar ratio

Return relative to maximum drawdown

0.15

3.75

-3.60

Martin ratio

Return relative to average drawdown

0.27

12.27

-12.00

SPRO vs. TQQQ - Sharpe Ratio Comparison

The current SPRO Sharpe Ratio is 0.12, which is lower than the TQQQ Sharpe Ratio of 2.92. The chart below compares the historical Sharpe Ratios of SPRO and TQQQ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


SPROTQQQDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.12

2.92

-2.80

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.18

0.43

-0.61

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.69

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.12

0.74

-0.86

Drawdowns

SPRO vs. TQQQ - Drawdown Comparison

The maximum SPRO drawdown since its inception was -97.46%, which is greater than TQQQ's maximum drawdown of -81.66%. Use the drawdown chart below to compare losses from any high point for SPRO and TQQQ.


Loading charts...

Drawdown Indicators


SPROTQQQDifference

Max Drawdown

Largest peak-to-trough decline

-97.46%

-81.66%

-15.80%

Max Drawdown (1Y)

Largest decline over 1 year

-39.80%

-36.97%

-2.83%

Max Drawdown (3Y)

Largest decline over 3 years

-68.89%

-58.04%

-10.85%

Max Drawdown (5Y)

Largest decline over 5 years

-97.13%

-81.66%

-15.47%

Max Drawdown (10Y)

Largest decline over 10 years

-81.66%

Current Drawdown

Current decline from peak

-87.31%

-0.76%

-86.55%

Average Drawdown

Average peak-to-trough decline

-62.29%

-18.52%

-43.77%

Ulcer Index

Depth and duration of drawdowns from previous peaks

22.79%

11.28%

+11.51%

Volatility

SPRO vs. TQQQ - Volatility Comparison

Spero Therapeutics, Inc. (SPRO) has a higher volatility of 17.76% compared to ProShares UltraPro QQQ (TQQQ) at 13.29%. This indicates that SPRO's price experiences larger fluctuations and is considered to be riskier than TQQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SPROTQQQDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.76%

13.29%

+4.47%

Volatility (6M)

Calculated over the trailing 6-month period

32.23%

36.04%

-3.81%

Volatility (1Y)

Calculated over the trailing 1-year period

52.43%

47.60%

+4.83%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

151.57%

66.53%

+85.04%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

124.80%

65.96%

+58.84%

Dividends

SPRO vs. TQQQ - Dividend Comparison

SPRO has not paid dividends to shareholders, while TQQQ's dividend yield for the trailing twelve months is around 0.36%.


PositionTTM20252024202320222021202020192018201720162015
SPRO
Spero Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
TQQQ
ProShares UltraPro QQQ
0.36%0.65%1.27%1.26%0.57%0.00%0.00%0.06%0.11%0.00%0.00%0.01%

Frequently Asked Questions


SPRO and TQQQ have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SPRO has higher volatility (17.76%) compared to TQQQ (13.29%). In terms of maximum drawdown, SPRO dropped -97.46% vs TQQQ's -81.66%.

TQQQ currently has the higher Sharpe Ratio (2.92 vs 0.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SPRO and TQQQ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer